Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A417NR | ISIN: CA0028221046 | Ticker-Symbol: ABL0
Frankfurt
06.06.25 | 08:04
14,700 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ABBOTT LABORATORIES CDR Chart 1 Jahr
5-Tage-Chart
ABBOTT LABORATORIES CDR 5-Tage-Chart

Aktuelle News zur ABBOTT LABORATORIES CDR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiPressmaster DMCC: Veteran-Owned Nate Woodard Acquires Abbotts Uniforms, Continuing Legacy of Excellence in Military and Uniformed Servicewear372Quantico, Virginia--(Newsfile Corp. - June 4, 2025) - Nate Woodard, a veteran-owned small business known for its commitment to craftsmanship and service, is proud to announce the acquisition of Abbott...
► Artikel lesen
MoAbbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?5
30.05.Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds4
29.05.Abbott reports positive dual-chamber pacemaker results3
28.05.An Abbott competitor drops out - plus, a special circumstance for Nvidia earnings54
28.05.Research and Markets: Europe Cervical Cancer Screening Market Research and Forecast Report 2025-2033 Featuring Abbott Laboratories, Hologic, Becton, Siemens, Roche Diagnostics, Quest Diagnostics, Cardinal Health - ResearchAndMarkets.com586The "Europe Cervical Cancer Screening Market Size and Share Analysis Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Europe Cervical...
► Artikel lesen
28.05.How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott10
ABBOTT LABORATORIES CDR Aktie jetzt für 0€ handeln
28.05.Abbott Stock Gains Following FDA Approval of the Tendyne System4
28.05.Abbott Gains FDA Approval for Tendyne, Strengthening Its Minimally Invasive Heart Portfolio4
27.05.Abbott gets FDA nod for Tendyne valve for mitral valve disease5
27.05.FDA approves Abbott mitral valve replacement device that doesn't require open-heart surgery6
27.05.Abbott Announces FDA Approval For Tendyne Transcatheter Mitral Valve Replacement System329NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement...
► Artikel lesen
27.05.Abbotts Tendyne-Klappe erhält FDA-Zulassung für Mitralklappenersatz9
27.05.Abbott Receives FDA Approval for Tendyne, First-of-Its-Kind Device to Replace the Mitral Valve Without Open-Heart Surgery415The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular...
► Artikel lesen
24.05.Texas macht Ernst: Gouverneur Abbott unterstützt staatliche Bitcoin-Reserve
22.05.Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?21
22.05.Sequel MedTech to pair automated insulin delivery system with Abbott's future dual glucose-ketone sensor4
20.05.Solid Results Boosted Abbott Laboratories' (ABT) Performance in Q16
19.05.Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs4
18.05.Abbott Laboratories (ABT)'s Libre Linked to Fewer Heart Hospitalizations in Diabetes6
Weiter >>
253 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1